- Home
- GLSI vs ASPS Comparison
GLSI vs ASPS Comparison
Compare GLSI & ASPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLSI
- ASPS
- Stock Information
- Founded
- GLSI 2006
- ASPS 1999
- Country
- GLSI United States
- ASPS Luxembourg
- Employees
- GLSI N/A
- ASPS N/A
- Industry
- GLSI Biotechnology: Pharmaceutical Preparations
- ASPS Other Consumer Services
- Sector
- GLSI Health Care
- ASPS Consumer Discretionary
- Exchange
- GLSI Nasdaq
- ASPS Nasdaq
- Market Cap
- GLSI 134.6M
- ASPS 150.8M
- IPO Year
- GLSI 2020
- ASPS N/A
- Fundamental
- Price
- GLSI $11.75
- ASPS $11.42
- Analyst Decision
- GLSI Strong Buy
- ASPS
- Analyst Count
- GLSI 1
- ASPS 0
- Target Price
- GLSI $39.00
- ASPS N/A
- AVG Volume (30 Days)
- GLSI 78.4K
- ASPS 41.8K
- Earning Date
- GLSI 08-13-2025
- ASPS 07-24-2025
- Dividend Yield
- GLSI N/A
- ASPS N/A
- EPS Growth
- GLSI N/A
- ASPS N/A
- EPS
- GLSI N/A
- ASPS N/A
- Revenue
- GLSI N/A
- ASPS $168,271,000.00
- Revenue This Year
- GLSI N/A
- ASPS $38.29
- Revenue Next Year
- GLSI N/A
- ASPS N/A
- P/E Ratio
- GLSI N/A
- ASPS N/A
- Revenue Growth
- GLSI N/A
- ASPS 12.96
- 52 Week Low
- GLSI $8.06
- ASPS $3.46
- 52 Week High
- GLSI $16.50
- ASPS $15.96
- Technical
- Relative Strength Index (RSI)
- GLSI 53.88
- ASPS 49.53
- Support Level
- GLSI $11.16
- ASPS $9.30
- Resistance Level
- GLSI $11.73
- ASPS $11.86
- Average True Range (ATR)
- GLSI 0.74
- ASPS 1.41
- MACD
- GLSI -0.08
- ASPS -0.36
- Stochastic Oscillator
- GLSI 42.91
- ASPS 26.43
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.